Like another company going public via SPAC giving you access to the IPOs it’s choosing to shun.
The greatest financial performance artist in history has settled for the easy and derivative.
The last year really could have gone somewhat better for SoftBank.
The case of Adam Neumann vs. Masa Son will be one for the books.
Masa Son’s got bad news for the Saudis.
In his latest piece of financial performance art, Masa Son is getting sued by himself.
Son himself would have the stones to do it, of course, but does Not Adam Neumann?
On second thought, SoftBank might not need the extra $3 billion in equity, thanks.
He gets to sell Sprint and its $40 billion in debt and lives to do something else bizarre.
The Silicon Valley disruptor/kombucha distributor’s new high priest is, uh, a real-estate executive.
You’re accredited and you’re accredited and YOU. ARE. ALL. ACCREDITED!
Good news: The company can still pay 80% of you (and also Adam Neumann) (for now).
One solitary slide in the WeWork autopsy report to SoftBank investors is a true encapsulation of the artist's soul.
The Adam Neumann platinum parachute lawsuits are coming in hot, and the first one is a doozy.
In fact, Mr. Neri Oxman thinks the whole thing is worth roughly $0.
Seeing a hypothetical $40 billion go up in allegorical smoke is having an impact on the greatest living performance artist in finance.
Jay Clayton's people come to the conclusion that this IPO market might not be technically criminal, but it is certainly very extremely dumb.
Masa Son remains clearly determined to make Neumann look like a transformative business genius.
SoftBank is ready to fix WeWork because co-dependent relationships are toxic.
SoftBank is ready to admit that it needs WeWork to survive.
Average comp is down 50% at 200 West Street, unless you're a robot, in which case, you're taking John Rogers' job.
What's left of We is hoping JPM will pony up $2 billion to keep the kombucha taps running, but that would almost certainly come with Dimon-strenght strings attached.
Officially pulling the IPO is going to hurt, but it's time for pain at We.